Literature DB >> 23222892

Time on dialysis and cancer risk after kidney transplantation.

Germaine Wong1, Robin M Turner, Jeremy R Chapman, Martin Howell, Wai H Lim, Angela C Webster, Jonathan C Craig.   

Abstract

BACKGROUND: Increasing time on dialysis is an established risk factor for certain cancer types for patients on dialysis, but the relationship between the time on dialysis and cancer risk after transplantation is unclear. We aimed to determine if the length of time on maintenance dialysis before the first kidney transplantation was associated with the risk of site-specific and overall incident cancers after transplantation.
METHODS: Using the Australia and New Zealand Dialysis and Transplant Registry, we assessed the association between both all cancers (except for nonmelanocytic skin cancers) and site-specific cancer incidence and the duration on dialysis before the first transplantation using adjusted Cox proportional hazards and competing risk models.
RESULTS: Over a median follow-up of 4.4 years (interquartile range, 1.7-7.7 years), the total cumulative incidence of all cancers after the first kidney transplantation was 15.0 per 1000 patient-years. There was a linear relationship between the duration of dialysis and the risk of cancer after transplantation (Ptrend=0.02). The excess risks for lung and urinary tract cancers were highest among recipients who had been on dialysis for the longest duration before transplantation (adjusted hazard ratio [95% confidence interval], 3.32 [1.00-11.4]; P=0.05 and 2.57 [1.33-4.95]; P=0.005, respectively).
CONCLUSION: Increasing time on dialysis is a significant risk factor for common solid organ cancers, such as lung cancer, and urinary tract cancers in kidney transplant recipients, irrespective of age. Strategies to improve cancer surveillance among recipients who had been on dialysis for a longer time may be warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23222892     DOI: 10.1097/TP.0b013e31827743b4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  21 in total

Review 1.  Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.

Authors:  Troy D Hubbard; Iain A Murray; Gary H Perdew
Journal:  Drug Metab Dispos       Date:  2015-06-03       Impact factor: 3.922

Review 2.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

3.  Incidence, risk factors and outcomes of malignancies after kidney transplantation in Singapore: a 12-year experience.

Authors:  Su Hooi Teo; Kian-Guan Lee; Gek Hsiang Lim; Si Xuan Koo; Maria Erika Ramirez; Khuan Yew Chow; Terence Kee
Journal:  Singapore Med J       Date:  2018-10-10       Impact factor: 1.858

4.  Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.

Authors:  M Lee Sanders; Jason H Karnes; Josh C Denny; Dan M Roden; T Alp Ikizler; Kelly A Birdwell
Journal:  Transplant Direct       Date:  2015-05

Review 5.  Renal cancer in kidney transplanted patients.

Authors:  Giovanni M Frascà; Silvio Sandrini; Laura Cosmai; Camillo Porta; William Asch; Matteo Santoni; Chiara Salviani; Antonia D'Errico; Deborah Malvi; Emilio Balestra; Maurizio Gallieni
Journal:  J Nephrol       Date:  2015-07-23       Impact factor: 3.902

Review 6.  De Novo Malignancies after Kidney Transplantation.

Authors:  David Al-Adra; Talal Al-Qaoud; Kevin Fowler; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

7.  Urothelial carcinoma of an allograft ureter 10 years after deceased donor kidney transplantation.

Authors:  Kevin P Gaughan; Usman Haroon; Niall F Davis; Ponnusamy Mohan
Journal:  BMJ Case Rep       Date:  2018-05-12

8.  Risk factors and incidence of malignant neoplasms after kidney transplantation at a single institution in Japan.

Authors:  Kengo Horie; Tomohiro Tsuchiya; Koji Iinuma; Yuka Maekawa; Keita Nakane; Taku Kato; Kosuke Mizutani; Takuya Koie
Journal:  Clin Exp Nephrol       Date:  2019-08-01       Impact factor: 2.801

9.  Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.

Authors:  Vikas R Dharnidharka; Abhijit S Naik; David Axelrod; Mark A Schnitzler; Huiling Xiao; Daniel C Brennan; Dorry L Segev; Henry Randall; Jiajing Chen; Bertram Kasiske; Krista L Lentine
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 10.  Malignancies after pediatric kidney transplantation: more than PTLD?

Authors:  Martin Mynarek; Kais Hussein; Hans H Kreipe; Britta Maecker-Kolhoff
Journal:  Pediatr Nephrol       Date:  2013-09-24       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.